Global RNA Targeting Small Molecule Drug Discovery Market Size and Forecast 2023-2032|F. Hoffmann-La Roche Ltd , Merck & Co. Inc, Bayer AG, Novartis AG, Sanofi SA,

The RNA Targeting Small Molecule Drug Discovery Global Market Report 2023, provides comprehensive information on the RNA targeting small molecule drug discovery market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The RNA Targeting Small Molecule Drug Discovery Market’s Growth:

https://www.thebusinessresearchcompany.com/report/RNA-targeting-small-molecule-drug-discovery-global-market-report

As per The Business Research Company’s RNA Targeting Small Molecule Drug Discovery Global Market Report 2023, the global RNA targeting small molecule drug discovery market is expected to grow from $1.18 billion in 2022 to $1.45 billion in 2023 at a compound annual growth rate (CAGR) of 23.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The RNA targeting small molecule drug discovery market is expected to reach $3.21 billion in 2027 at a CAGR of 21.9%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12480&type=smp

Artificial intelligence (AI) integration in drug discovery is a key trend gaining popularity in the RNA targeting small molecule drug discovery market. Major companies in the RNA targeting small molecule drug discovery market are leveraging AI technology to accelerate drug discovery procedures to sustain their position in the market. For instance, in May 2023, Google Cloud, the cloud computing suite of Google, a US-based technology company, launched Target and Lead Identification Suite and Multiomics Suite to facilitate the drug discovery process. The Multiomics Suite expedites the identification and analysis of genetic data, assisting businesses in designing precision medicines. The Target and Lead Identification Suite aids researchers in better understanding the role of amino acids and predicting the structure of proteins.

The RNA targeting small molecule drug discovery market is segmented:

1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)

2) By Technology: CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies

3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas

4) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods

5) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other Applications

North America was the largest region in the RNA targeting small molecule drug discovery market in 2022.

The table of contents in TBRC’s RNA targeting small molecule drug discovery market report includes:

1. Executive Summary

2. RNA Targeting Small Molecule Drug Discovery Market Characteristics

3. RNA Targeting Small Molecule Drug Discovery Market Trends And Strategies

4. RNA Targeting Small Molecule Drug Discovery Market – Macro Economic Scenario

5. Global RNA Targeting Small Molecule Drug Discovery Market Size and Growth

.

.

.

26. South America RNA Targeting Small Molecule Drug Discovery Market

27. Brazil RNA Targeting Small Molecule Drug Discovery Market

28. Middle East RNA Targeting Small Molecule Drug Discovery Market

29. Africa RNA Targeting Small Molecule Drug Discovery Market

30. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles

Top Major Players:

• Hoffmann-La Roche Ltd
• Merck & Co. Inc
• Bayer AG
• Novartis AG
• Sanofi SA

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model